about
STING: infection, inflammation and cancerCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor MicroenvironmentThe interplay of immunotherapy and chemotherapy: harnessing potential synergiesRAD51 interconnects between DNA replication, DNA repair and immunity.Comparison of the purity and vitality of natural killer cells with different isolation kits.Suppression of inflammation by the rhizome of Anemarrhena asphodeloides via regulation of nuclear factor-κB and p38 signal transduction pathways in macrophages.Immunotherapy at large: Balancing tumor immunity and inflammatory pathologyBalancing the innate immune system in tumor development.Efficacy of traditional Chinese medicine in treating cancer.Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinomaGambogenic acid inhibits LPS-simulated inflammatory response by suppressing NF-κB and MAPK in macrophages.Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery.Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma.Alterations in macrophages and monocytes from tumor-bearing mice: evidence of local and systemic immune impairment.Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity.STING signalling: an emerging common pathway in autoimmunity and cancer.Diverse roles of STING-dependent signaling on the development of cancerAnti-Inflammatory Effect of Piper attenuatum Methanol Extract in LPS-Stimulated Inflammatory Responses.Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor DevelopmentTwo SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia.Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease.Manipulation of Innate Immunity for Cancer Therapy in Dogs.The role of innate lymphoid cells in health and disease.Influential factors on radiotherapy efficacy and prognosis in patients with secondary lymph node metastasis after esophagectomy of thoracic esophageal squamous cell carcinoma.Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.miR-301, Pleiotropic MicroRNA in Regulation of Inflammatory Bowel Disease and Colitis-Associated Cancer.Anti-inflammatory effects of a novel compound, MPQP, through the inhibition of IRAK1 signaling pathways in LPS-stimulated RAW 264.7 macrophages.Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
P2860
Q26776009-8034D0C6-D8D1-4605-A298-B0CB068A7A84Q28077126-800776C5-32D1-4387-9177-53E3A4F867DFQ28081893-43E3602B-04D1-4099-A83B-725B6613BA01Q33636125-8EACE957-411B-4318-89E5-FD7ACB654E82Q33724240-3E11C119-D2B8-4DDE-BC34-ABD37C4E8ECAQ33742110-38CAC2CD-66A8-4CC3-ACD5-6C4B9DE91EE4Q33856217-41BA299D-4B13-4847-ACE1-ABDD369B8D85Q35236394-B1E97AEA-B6A8-4E3B-85E4-0204CE5FA791Q36502153-87BEE2D7-E2E9-4FAC-9674-9369424170CAQ36742929-6290586A-6AA8-43B3-A32C-DB842631C3F0Q36954845-318C266C-FF61-46BA-811C-A960C240F053Q37327632-75F6A162-AD00-45FB-879C-82C3713DC488Q37354169-EACABD19-B581-4AE5-A0F2-DF0966EA072CQ38160777-EE29627E-70D4-4177-BBB9-7EECDE329F5EQ39137044-7A34493B-5C4E-49EB-8696-9B2D9A7D87C3Q39445737-132FE52F-C6BF-43FF-AA8E-2BBEBAE23B80Q41140047-BD4014B1-D406-4538-B802-BECCFA24240BQ41294028-406F7732-0370-4EE0-AB54-03546F2C47ABQ41684112-D8462B0F-4182-45EF-8138-AB169A5F109BQ41785520-2F8DBDAE-4ADC-44C6-B8D3-95C2277BD02BQ45848248-08CC0B30-991A-4C7F-AD6F-6152CBA8610DQ47100766-875D4838-D99D-4492-AEB8-D957F02F6FA6Q47137850-5C9DDC6C-53FD-4220-8E35-D529D6CF4E60Q48146269-63FD53B8-3074-48FD-A049-0784F35CE429Q50024652-6CD3F70F-277A-46C4-B01D-5AC476B5ECE1Q50105682-84301234-BE5F-4F4A-97C2-B10B77CD6659Q52337480-610663B0-52C9-4451-89C9-2F85299EFBE5Q54978064-6AF49384-2F23-4610-88BD-837BA3CF1C24Q55244957-78DCD691-D999-45C2-80CD-645750FAFBC8
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Innate immune cells in inflammation and cancer
@ast
Innate immune cells in inflammation and cancer
@en
Innate immune cells in inflammation and cancer
@nl
type
label
Innate immune cells in inflammation and cancer
@ast
Innate immune cells in inflammation and cancer
@en
Innate immune cells in inflammation and cancer
@nl
prefLabel
Innate immune cells in inflammation and cancer
@ast
Innate immune cells in inflammation and cancer
@en
Innate immune cells in inflammation and cancer
@nl
P2093
P3181
P1476
Innate immune cells in inflammation and cancer
@en
P2093
Nicola Gagliani
Richard A Flavell
Roni Nowarski
P3181
P356
10.1158/2326-6066.CIR-13-0081
P407
P50
P577
2013-08-01T00:00:00Z